Genetic variants in gastric cancer: Risks and clinical implications

Exp Mol Pathol. 2017 Aug;103(1):101-111. doi: 10.1016/j.yexmp.2017.07.004. Epub 2017 Jul 20.

Abstract

Cancer is a multifactorial disease that involves many molecular alterations. Gastric cancer (GC) is the third leading cause of cancer death worldwide. GC is a highly heterogeneous disease with different molecular and genetics features. Therefore, this review focuses on an overview of the genetic aspects of gastric cancer by highlighting the important impact and role of deletions and/or duplications of chromosomal segments, genomic variants, H. pylori infection and interleukin variants, as found in gene expression and newly proposed molecular classification studies. The challenge is to better understand the mechanisms and different pathways that lead to the development and progression of GC.

Keywords: CNV; GWAS; Gastric cancer; Interleukin; Polymorphism; mRNA expression.

Publication types

  • Review

MeSH terms

  • DNA Copy Number Variations
  • Genome-Wide Association Study
  • Helicobacter Infections / complications
  • Helicobacter Infections / diagnosis
  • Helicobacter pylori
  • Humans
  • Interleukins / genetics
  • Interleukins / metabolism
  • Meta-Analysis as Topic
  • Polymorphism, Genetic*
  • Signal Transduction
  • Stomach Neoplasms / diagnosis*
  • Stomach Neoplasms / etiology
  • Stomach Neoplasms / genetics*

Substances

  • Interleukins